A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial] - Maiwall, R; Kumar, A; Pasupuleti, SS R (J Hepatol, 2022)
et al.